Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.7%

1 terminated/withdrawn out of 134 trials

Success Rate

94.4%

+7.9% vs industry average

Late-Stage Pipeline

13%

17 trials in Phase 3/4

Results Transparency

6%

1 of 17 completed trials have results

Key Signals

39 recruiting1 with results

Enrollment Performance

Analytics

Phase 2
39(40.2%)
N/A
34(35.1%)
Phase 3
15(15.5%)
Phase 1
6(6.2%)
Phase 4
2(2.1%)
Early Phase 1
1(1.0%)
97Total
Phase 2(39)
N/A(34)
Phase 3(15)
Phase 1(6)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (134)

Showing 20 of 134 trials
NCT06561308Phase 2Recruiting

Clinical Efficacy Study of PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer

Role: collaborator

NCT07709585Phase 2Not Yet Recruiting

Befotertinib Plus Chemotherapy With an MRD-guided Adaptive Strategy for Treatment Escalation and Response Optimization in EGFR-mutated NSCLC Patients

Role: collaborator

NCT06577792Not ApplicableActive Not Recruiting

Lobectomy-First vs. Lymphadenectomy-First for Operable NSCLC (LOFTY)

Role: collaborator

NCT07692906Not ApplicableNot Yet Recruiting

Multimodal Evaluation-Guided Surveillance-Intervention With Endoscopic Selective Neck Dissection for Post-Radiotherapy N3 Nasopharyngeal Carcinoma

Role: collaborator

NCT04793672Completed

Establishment of Tongue Image Database and Machine Learning Model for Malignant Tumors Diagnosis

Role: collaborator

NCT07309991Recruiting

Postoperative Hypoxemia Increases the Risk of Anastomotic Leak After Radical Esophagectomy

Role: collaborator

NCT07590596Not Yet Recruiting

Preoperative Decision-Making in Patients With Pulmonary Nodules Suspected of Lung Cancer

Role: lead

NCT07013461Recruiting

International Collaborative Study on AJCC/UICC TNM-10 for Nasopharyngeal Cancer

Role: collaborator

NCT07561983Phase 2Not Yet Recruiting

Tislelizumab Plus Chemotherapy and BACE for Unresectable NSCLC

Role: lead

NCT05191485Recruiting

Shared Decision Making in Patients With Lung Cancer

Role: lead

NCT06836869Not ApplicableRecruiting

Modified Tumor-free Techniques Operation to Cervical Cancer

Role: collaborator

NCT07402525Not ApplicableRecruiting

Postoperative Radiotherapy for Early-stage Oral Tongue Squamous Cell Carcinoma Patients With Risk Factors: a Prospective, Multicenter, Randomized Controlled, Open-labelled Trial

Role: collaborator

NCT07388758Phase 2Not Yet Recruiting

Scipibaimab Combined With Tislelizumab in Patients With First-Line Treatment-Failed Recurrent/Metastatic Nasopharyngeal Carcinoma

Role: collaborator

NCT07294872Phase 1Not Yet Recruiting

A Study of TIL in Advanced Solid Tumors (CZ)

Role: collaborator

NCT07338396Not Yet Recruiting

A Prospective Multicenter Study of the Association Between TCM Syndromes and EGFR-TKI Efficacy in Lung Cancer Patients

Role: collaborator

NCT06524427Not ApplicableRecruiting

Robot-Assisted vs. Video-Assisted Lobectomy for NSCLC (RAVAR)

Role: collaborator

NCT06518655Recruiting

Differentiation of Benign and Malignant Pulmonary Nodules by Volatile Organic Compounds in Human Exhaled Breath

Role: collaborator

NCT07269912Not Yet Recruiting

Application of Multimodal MRI in Histological Grading and Prognostic Assessment of Rectal Cancer

Role: lead

NCT06007586Phase 3Completed

Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients

Role: lead

NCT05189730Phase 2Active Not Recruiting

Selected Chemotherapy Combined Immunotherapy Treated High Risk Patient After NCRT in Resected Locally Advanced ESCC

Role: lead